Tandem Health, an AI-powered medical assistant, has raised a $100 million Series B funding round led by the €5 billion Scaleup Europe Fund. The Swedish startup plans to accelerate its growth and expand its AI-native clinic operating system.
TL;DR
- Tandem Health raises $100M Series B to expand its AI medical assistant across Europe.
- The funding will support the company's growth among leading care providers and the development of an AI-native clinic operating system.
- Tandem Health's AI assistant reduces administrative tasks for clinicians by 29%.
What happened
Tandem Health, a Swedish AI medical assistant startup, has completed a $100 million Series B funding round. The round was led by the €5 billion Scaleup Europe Fund, managed by EQT, a Stockholm-based private equity firm. This is the Scaleup Europe Fund's first investment in AI healthcare.
Tandem Health was founded to reduce the administrative burden on clinical healthcare using AI. Its AI medical assistant generates notes during patient consultations, provides clinical decision support, and handles documentation and coding. The company has partnerships with major healthcare providers, including a collaboration with Accurx that gives hundreds of thousands of NHS practitioners access to its technology.
The Series B funding round includes backing from investors such as Kinnevik, Northzone, Amino Collective, and Visionaries. This follows a $50 million Series A round last year. Tandem Health is used by 10,000 care organizations across 14 European countries.
Why it matters
This funding will enable Tandem Health to accelerate its growth among Europe's leading care providers. The company plans to expand its AI-native clinic operating system, which will manage patient flows and handle additional clinical tasks.
The investment highlights the growing interest in AI solutions for healthcare, particularly in reducing administrative burdens and improving efficiency. Tandem Health's AI assistant has been shown to reduce the time clinicians spend on administrative tasks by 29%, according to the company.
The competitive landscape for AI in healthcare is heating up, with companies like Tandem Health aiming to set standards for AI integration in European healthcare systems. This funding round positions Tandem Health as a key player in this emerging market.
Key facts
- Tandem Health raises $100 million Series B funding round.
- Scaleup Europe Fund, managed by EQT, leads the investment.
- The funding includes backing from Kinnevik, Northzone, Amino Collective, and Visionaries.
- Tandem Health's AI assistant reduces administrative tasks for clinicians by 29%.
- The company is used by 10,000 care organizations across 14 European countries.
- Tandem Health plans to expand its AI-native clinic operating system.
- The Series B round follows a $50 million Series A round last year.
- Tandem Health has a partnership with Accurx, giving access to hundreds of thousands of NHS practitioners.
Context
The healthcare industry is increasingly turning to AI to streamline operations and improve patient care. Tandem Health's AI medical assistant is part of a broader trend of AI integration in healthcare, aiming to reduce administrative burdens and enhance clinical decision-making.
Europe's healthcare systems are under significant strain, and AI solutions like those offered by Tandem Health present a promising avenue for improvement. The company's focus on developing AI solutions tailored to European markets sets it apart from competitors that may rely on retrofitted solutions.
The investment in Tandem Health by the Scaleup Europe Fund underscores the growing interest in AI healthcare startups. As the healthcare industry continues to evolve, AI solutions that can effectively integrate into existing systems and improve efficiency are likely to see increased investment and adoption.
